ENOV · NYSE · Medical - Devices

Enovis (ENOV)

Builds orthopedic implants, bracing, rehabilitation, and recovery products for care teams and patients.

$18.27
vs last close+0.23 (+1.27%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Apr 2025Q2 FY25Jul 2025Q3 FY25Oct 2025Q4 FY25Dec 2025Q1 FY26Apr 2026Q2 FY26Jul 2026
Revenue418455516525505561559565549576589583
Cost of revenue175191218236219253227230262226266224
Gross profit243264298289286308332335287349324359
263270333333318972375351278301303342
Research & development201823232024293130313232
204211256264250258269267248270272264
General & administrative00000000000264
Other expenses394154464869178530−1046
Operating income−20−6−35−44−32−665−43−169482017
−513−4417−11−9−14−10−576−558−20−10
Interest income00000000120100
Interest expense64201711999218198
Other non-operating income−1−1824−34005055555002
Income before tax−268−79−27−43−674−57−26−567−51017
Income tax expense−65−7−9−930−2114999
Net income from continuing operations−193−72−18−34−704−56−36−571−519−8−1
Discontinued operations1700020000−200
Net income−33−72−19−32−703−56−37−571−521−9−1
EPS, basic−$0.34$0.05−$1.32−$0.34−$0.57−$12.05−$0.99−$0.64−$10.06−$9.17−$0.15−$0.02
EPS, diluted−$0.34$0.05−$1.32−$0.34−$0.57−$12.05−$0.99−$0.64−$10.06−$9.17−$0.15−$0.02
Weighted average shares, basic555555555658575757575758
Weighted average shares, diluted555555555658575757575758
EBITDA3669145540−5902355−472−4259387
Depreciation & amortization555773667174717274777371
EBIT−2012−59−10−32−665−48−16−546−5022016